Literature DB >> 23102011

Eudragit: a technology evaluation.

Seema Thakral1, Naveen K Thakral, Dipak K Majumdar.   

Abstract

INTRODUCTION: Eudragit is the brand name for a diverse range of polymethacrylate-based copolymers. It includes anionic, cationic, and neutral copolymers based on methacrylic acid and methacrylic/acrylic esters or their derivatives. AREAS COVERED: In this review, the physicochemical characteristics and applications of different grades of Eudragit in colon-specific/enteric-coated/sustained release drug delivery and taste masking have been addressed. EXPERT OPINION: Eudragits are amorphous polymers having glass transition temperatures between 9 to > 150(o)C. Eudragits are non-biodegradable, nonabsorbable, and nontoxic. Anionic Eudragit L dissolves at pH > 6 and is used for enteric coating, while Eudragit S, soluble at pH > 7 is used for colon targeting. Studies in human volunteers have confirmed that pH drops from 7.0 at terminal ileum to 6.0 at ascending colon, and Eudragit S based systems sometimes fail to release the drug. To overcome the shortcoming, combination of Eudragit S and Eudragit L which ensures drug release at pH < 7 has been advocated. Eudragit RL and RS, having quaternary ammonium groups, are water insoluble, but swellable/permeable polymers which are suitable for the sustained release film coating applications. Cationic Eudragit E, insoluble at pH ≥ 5, can prevent drug release in saliva and finds application in taste masking.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23102011     DOI: 10.1517/17425247.2013.736962

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  56 in total

1.  Reduced ABCB1 Expression and Activity in the Presence of Acrylic Copolymers.

Authors:  Ramin Mohammadzadeh; Behzad Baradaran; Hadi Valizadeh; Bahman Yousefi; Parvin Zakeri-Milani
Journal:  Adv Pharm Bull       Date:  2014-02-07

2.  Ionic liquids for oral insulin delivery.

Authors:  Amrita Banerjee; Kelly Ibsen; Tyler Brown; Renwei Chen; Christian Agatemor; Samir Mitragotri
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

Review 3.  Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.

Authors:  Abhijit A Date; Justin Hanes; Laura M Ensign
Journal:  J Control Release       Date:  2016-06-09       Impact factor: 9.776

4.  Gastrointestinal synthetic epithelial linings.

Authors:  Junwei Li; Thomas Wang; Ameya R Kirtane; Yunhua Shi; Alexis Jones; Zaina Moussa; Aaron Lopes; Joy Collins; Siddartha M Tamang; Kaitlyn Hess; Rameen Shakur; Paramesh Karandikar; Jung Seung Lee; Hen-Wei Huang; Alison Hayward; Giovanni Traverso
Journal:  Sci Transl Med       Date:  2020-08-26       Impact factor: 17.956

5.  In vitro Approaches to Support Bioequivalence and Substitutability of Generic Proton Pump Inhibitors via Nasogastric Tube Administration.

Authors:  Ping Ren; Minglei Cui; Om Anand; Li Xia; Zhuojun J Zhao; Dajun Sun; Trueman Sharp; Dale P Conner; John Peters; Wenlei Jiang; Ethan Stier; Xiaojian Jiang
Journal:  AAPS J       Date:  2017-09-06       Impact factor: 4.009

6.  Electrically controlled drug release using pH-sensitive polymer films.

Authors:  S Ephraim Neumann; Christian F Chamberlayne; Richard N Zare
Journal:  Nanoscale       Date:  2018-05-31       Impact factor: 7.790

Review 7.  Impact of gastric and bowel surgery on gastrointestinal drug delivery.

Authors:  Susan Hua; Ephraem C Lye
Journal:  Drug Deliv Transl Res       Date:  2022-05-18       Impact factor: 4.617

8.  Live-vaccinia virus encapsulation in pH-sensitive polymer increases safety of a reservoir-targeted Lyme disease vaccine by targeting gastrointestinal release.

Authors:  Aurelie Kern; Chensheng W Zhou; Feng Jia; Qiaobing Xu; Linden T Hu
Journal:  Vaccine       Date:  2016-08-05       Impact factor: 3.641

Review 9.  Physical approaches to masking bitter taste: lessons from food and pharmaceuticals.

Authors:  John N Coupland; John E Hayes
Journal:  Pharm Res       Date:  2014-09-10       Impact factor: 4.200

10.  Site-specific intestinal DMT1 silencing to mitigate iron absorption using pH-sensitive multi-compartmental nanoparticulate oral delivery system.

Authors:  Yingfang Fan; Harkiranpreet Kaur Dhaliwal; Archita Venugopal Menon; JuOae Chang; Jee Eun Choi; Mansoor M Amiji; Jonghan Kim
Journal:  Nanomedicine       Date:  2019-10-15       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.